News
- Author:
- Randy Dotinga
Publish date: January 23, 2023
Skin lesions are more likely to precede systemic illness, and overall lesion numbers are lower.
News
- Author:
- Randy Dotinga
Publish date: January 20, 2023
For CML patients in remission, specialists suggest trying drug omission – which often yields good outcomes and a reprieve from side effects.
News
- Author:
- Randy Dotinga
Publish date: January 4, 2023
The doctor was accused of engaging in dialogue to respond to viewers’ online questions while a surgical procedure remained actively ongoing, among ...
News
- Author:
- Randy Dotinga
Publish date: December 22, 2022
Presidential symposium plumbs the mysteries of an “extraordinarily stealthy” virus, considers postvaccine blood clots.
News
- Author:
- Randy Dotinga
Publish date: December 21, 2022
By virtue of their young age and stage of mental and emotional development, children and adolescents are vulnerable to manipulation and exploitatio...
Article
- Author:
- Randy Dotinga
Publish date: December 20, 2022
First-line treatment with expensive medication should become standard, researcher says.
News
- Author:
- Randy Dotinga
Publish date: December 16, 2022
Currently, there’s no Food and Drug Administration–approved treatment for agitation in AD.
News
- Author:
- Randy Dotinga
Publish date: December 16, 2022
It’s time to rethink the guidelines on nutritional supplementation for the most premature babies, researchers said.
News
- Author:
- Randy Dotinga
Publish date: December 14, 2022
Exorbitant efgartigimod meets primary endpoint in only 21.8% of patients with chronic disease.
News
- Author:
- Randy Dotinga
Publish date: December 12, 2022
New research showed ibrutinib outperformed HSCT for treating younger patients with mantle cell lymphoma.
News
- Author:
- Randy Dotinga
Publish date: December 12, 2022
Evidence suggests the drug’s receptor targets “have the potential to modulate neurotransmitter systems that are essential for regulation of cogniti...
News
- Author:
- Randy Dotinga
Publish date: December 12, 2022
Immunotherapy and targeted therapy appear to be paying dividends, new study finds.
News
- Author:
- Randy Dotinga
Publish date: December 11, 2022
New findings from Italy: Anti-bacterial diet, long the scourge of stem-cell transplant patients, doesn’t lower risk of infection.
News
- Author:
- Randy Dotinga
Publish date: December 10, 2022
Asians/Pacific Islanders with pulmonary embolism faced the lowest risk of hospitalization but died at the highest rate, new study finds.
News
- Author:
- Randy Dotinga
Publish date: December 5, 2022
Experts have voiced alarm at the scarcity and cost of fludarabine, an old drug deemed crucial to cellular therapy for leukemia.
